Novocure

medical devices

About

Novocure is an international oncology company founded in 2000 by Professor Yoram Palti, known for discovering the therapeutic effects of Tumor Treating Fields (TTFields) on cancer cells. Headquartered in Saint Helier, Jersey, UK, Novocure operates in the United States, Germany, Japan, Greater China, and other international markets. The company specializes in developing and commercializing delivery systems that utilize its proprietary TTFields technology. This non-invasive treatment approach targets solid tumor cancer cells by using low-intensity, intermediate-frequency electric fields to disrupt their division and inhibit tumor growth. Novocure's key products include Optune Lua, for malignant pleural mesothelioma, and Optune Gio, for glioblastoma. Both products are designed to be used alongside standard chemotherapy regimens to enhance treatment efficacy. Novocure is committed to expanding the applications of TTFields therapy through clinical research, having participated in over 80 medical trials worldwide.

Technologies

Cloudflare DNS Rackspace MailGun Mimecast Microsoft Office 365 UptimeRobot WP Engine Netlify Remote

Keywords

medical device oncology cancer glioblastoma neurooncology medical devices medical health care medical/dental instruments medical equipment manufacturing cancer milestones cancer therapies cancer therapy clinical trials cancer treatment milestones cancer therapy pipeline clinical trial sites optune gio market research metastatic cancer clinical trial patient recruitment clinical trial efficacy clinical trial publication cancer treatment pipeline clinical trial safety fda approval clinical trial milestones oncology innovation cancer therapy clinical trial data analysis cancer treatment approvals

Location

21 Neuhofstrasse, Baar, Canton of Zug, Switzerland, 6340

Related Companies

Companies in the same industry